Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
2565 |
issn |
1476-5381 0007-1188 |
issueIdentifier |
13 |
pageRange |
2554-2565 |
publicationName |
British Journal of Pharmacology |
startingPage |
2554 |
bibliographicCitation |
Andersson KE. PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol. 2018 Jul;175(13):2554–65. PMID: 29667180; PMCID: PMC6003652. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0665-3486 |
date |
2018-04-25^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC6003652 https://pubmed.ncbi.nlm.nih.gov/29667180 https://doi.org/10.1111/bph.14205 |
isPartOf |
https://portal.issn.org/resource/ISSN/1476-5381 https://portal.issn.org/resource/ISSN/0007-1188 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Andersson KE: PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol. 2018 Jul;175(13):2554-2565. doi: 10.1111/bph.14205. Epub 2018 Apr 25. |
discusses |
http://id.nlm.nih.gov/mesh/M0327633 http://id.nlm.nih.gov/mesh/M0545665 http://id.nlm.nih.gov/mesh/M0009685 http://id.nlm.nih.gov/mesh/M0014877 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D058986Q000494 http://id.nlm.nih.gov/mesh/D055808 http://id.nlm.nih.gov/mesh/D000068677Q000494 http://id.nlm.nih.gov/mesh/D009569Q000037 http://id.nlm.nih.gov/mesh/D006152Q000037 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D006152Q000378 http://id.nlm.nih.gov/mesh/D009569Q000378 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145068 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398744 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6719 |